Metabolic Research

5-Amino-1MQ

4.9/10

BioHarmony verdict

Neutral

5-Amino-1MQ is a synthetic NNMT-inhibitor research compound that cut fat mass in obese mice and raised NAD+ in cultured fat cells (Neelakantan 2018), but it has zero human trials. Oral 50 to 150 mg is the only route with pharmacokinetic support; injectable microgram doses are likely too low to work.

Read full report

What is 5-Amino-1MQ?

5-Amino-1MQ is a synthetic small molecule that blocks an enzyme called NNMT (nicotinamide N-methyltransferase), which in animal studies frees up raw material for NAD+ and helps mice lose fat (Neelakantan 2018) and rebuild aging muscle (Neelakantan 2019). It is marketed for fat loss, muscle and strength, energy, and longevity, and sold as a research compound rather than an approved drug or supplement. It has never been tested in a single human trial. Oral dosing of 50 to 150 mg is the only route with pharmacokinetic support, while the popular injectable microgram protocols are almost certainly too low to do anything.

From the BioHarmony report, reviewed 2026-09-08.

How it is thought to work

Blocks the NNMT enzyme, sparing nicotinamide for NAD+ and preserving methyl groups

Safety watch-outs

  • Heart palpitations, severe anxiety, or blood pressure spikes
  • Persistent insomnia despite morning-only dosing
  • Any product that acts like a diuretic or causes unexpected symptoms (possible counterfeit)
  • Pregnancy, breastfeeding, or active or prior cancer: stop and consult a medical professional

Full risk profile in the BioHarmony report.

Dosing as published

No approved-label or study protocol is recorded for 5-Amino-1MQ yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (2)

Attributed viewpoints, separate from primary research.

Trust & sourcing

US approvalInvestigational
CompoundingEligibility not established.
Last checked2026-07-13
Next review2026-10-11

The reviewed evidence for 5-amino-1MQ is preclinical. A published study describes NNMT inhibition and metabolic effects in cells and mouse models; it does not establish safety or effectiveness in humans.

Primary sources

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.